Cheng-Han Lee

Associate Professor

University of Alberta

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Biology Cancer Biology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

Maaike van der Aa

Netherlands Comprehensive Cancer Organisation

NETHERLANDS

View details

Gordana Popovic

AUSTRALIA

View details

Maria Jose Garcia

Instituto de Investigaciones Biomédicas Alberto Sols

SPAIN

View details

Martin Köbel

Associate Professor

University of Calgary

CANADA

View details

Peter Sinn

University Hospital

GERMANY

View details

Bea Wisman

department of gynecologic oncology university of groningen

NETHERLANDS

View details

Basile Tessier-Cloutier

Assistant Professor

McGill University

CANADA

View details

Usha Menon

Professor of Gynaecological Oncology

University College London

UNITED KINGDOM

View details

Gabriel DiMattia

Western University

CANADA

View details

Susan Ramus

Professor of Molecular Oncology

University of New South Wales

AUSTRALIA

View details

Paul Cohen

University of Western Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cheng-Han Lee

Research Interests

Explore related searches

Contact this professor

Articles (8)

Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma

CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition

EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity

Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression

Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma

Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix

p53 immunohistochemical analysis of fusion‐positive uterine sarcomas

Collaborators (11)

Maaike van der Aa

Gordana Popovic

Maria Jose Garcia

Martin Köbel

Peter Sinn

Bea Wisman

Basile Tessier-Cloutier

Usha Menon

Gabriel DiMattia

Susan Ramus

Paul Cohen

Make your next move.